These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36750861)

  • 41. Fighting non-communicable diseases in East Africa: assessing progress and identifying the next steps.
    Kraef C; Juma PA; Mucumbitsi J; Ramaiya K; Ndikumwenayo F; Kallestrup P; Yonga G
    BMJ Glob Health; 2020 Nov; 5(11):. PubMed ID: 33184064
    [TBL] [Abstract][Full Text] [Related]  

  • 42. How are countries dealing with their current cardio-vascular disease burden? A snapshot from the WHO Eastern Mediterranean Region (EMR).
    Hammerich A
    Glob Cardiol Sci Pract; 2018 Mar; 2018(1):1. PubMed ID: 29644228
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improving Information to Enable Effective Tobacco Control Intervention and Measure Progress Over Time: The Cambodia Country Experience.
    Rarick J; Kheam T; Daravuth Y; Tursan D'Espaignet E; Kashiwabara M; Chhordaphea C; Ritthiphakdee B
    Asian Pac J Cancer Prev; 2020 Jul; 21(S1):5-8. PubMed ID: 32649164
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessing the potential outcomes of achieving the World Health Organization global non-communicable diseases targets for risk factors by 2025: is there also an economic dividend?
    Devaux M; Lerouge A; Ventelou B; Goryakin Y; Feigl A; Vuik S; Cecchini M
    Public Health; 2019 Apr; 169():173-179. PubMed ID: 30876722
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Moving Towards Optimized Noncommunicable Disease Management in the ASEAN Region: Recommendations from a Review and Multidisciplinary Expert Panel.
    Castillo-Carandang NT; Buenaventura RD; Chia YC; Do Van D; Lee C; Duong NL; Ng CH; Robles YR; Santoso A; Sigua HS; Sukonthasarn A; Tan R; Viora E; Zakaria H; Brizuela GE; Ratnasingham P; Thomas M; Majumdar A
    Risk Manag Healthc Policy; 2020; 13():803-819. PubMed ID: 32765135
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A qualitative study of governance of evolving response to non-communicable diseases in low-and middle- income countries: current status, risks and options.
    Rani M; Nusrat S; Hawken LH
    BMC Public Health; 2012 Oct; 12():877. PubMed ID: 23067232
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Readiness, Availability and Utilization of Rural Vietnamese Health Facilities for Community Based Primary Care of Non-communicable Diseases: A CrossSectional Survey of 3 Provinces in Northern Vietnam.
    Duong DB; Minh HV; Ngo LH; Ellner AL
    Int J Health Policy Manag; 2019 Mar; 8(3):150-157. PubMed ID: 30980631
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of the COVID-19 pandemic on service delivery for noncommunicable diseases in the Eastern Mediterranean Region.
    Hammerich A; Fouad H; Elrayah EE; Slama S; El-Awa F; El-Berri H; Abdel Latif N
    East Mediterr Health J; 2022 Jul; 28(7):469-477. PubMed ID: 35959662
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Co-occurrence of behavioural risk factors for non-communicable diseases among 40-year and above aged community members in three regions of Myanmar.
    Mon AS; Win HH; Sandar WP; Walton P; Swe KH; Vervoort JPM; Landsman JA; Rusnak M; Koot JAR
    Open Res Eur; 2023; 3():77. PubMed ID: 38357680
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assuring Bangladesh's future: non-communicable disease risk factors among the adolescents and the existing policy responses.
    Biswas T; Azzopardi P; Anwar SN; de Vries TD; Encarnacion-Cruz LM; Hasan MM; Huda MM; Pervin S; Das Gupta R; Mitra DK; Rawal LB; Al Mamun A
    J Health Popul Nutr; 2022 May; 41(1):22. PubMed ID: 35578321
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modelling and prediction of global non-communicable diseases.
    Wang Y; Wang J
    BMC Public Health; 2020 Jun; 20(1):822. PubMed ID: 32487173
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantifying the global distribution of premature mortality from non-communicable diseases.
    Allen L; Cobiac L; Townsend N
    J Public Health (Oxf); 2017 Dec; 39(4):698-703. PubMed ID: 28184435
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Estimated Impacts of Alcohol Control Policies on NCD Premature Deaths in Thailand.
    Chaiyasong S; Gao J; Bundhamcharoen K
    Int J Environ Res Public Health; 2022 Aug; 19(15):. PubMed ID: 35954980
    [No Abstract]   [Full Text] [Related]  

  • 54. The dynamic of non-communicable disease control policy in Indonesia.
    Christiani Y; Dugdale P; Tavener M; Byles JE
    Aust Health Rev; 2017 May; 41(2):207-213. PubMed ID: 27209156
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Implementation of Childhood Obesity Related Policy Interventions in Malaysia-A Non Communicable Diseases Scorecard Project.
    Mok WKH; Hairi NN; Chan CMH; Mustapha FI; Saminathan TA; Low WY
    Int J Environ Res Public Health; 2021 Jun; 18(11):. PubMed ID: 34206056
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Developing an organizational capacity assessment tool and capacity-building package for the National Center for Prevention and Control of Noncommunicable Diseases in Iran.
    Bakhtiari A; Takian A; Ostovar A; Behzadifar M; Mohamadi E; Ramezani M
    PLoS One; 2023; 18(6):e0287743. PubMed ID: 37384743
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Baseline risk factor prevalence among adolescents aged 15-17 years old: findings from National Non-communicable Disease Monitoring Survey (NNMS) of India.
    Mathur P; Kulothungan V; Leburu S; Krishnan A; Chaturvedi HK; Salve HR; Amarchand R; Nongkynrih B; Ganeshkumar P; Urs K S V; Laxmaiah A; Boruah M; Kumar S; Patro BK; Raghav PR; Rajkumar P; Sarma PS; Sharma R; Tambe M; Arlappa N; Mahanta TG; Bhuyan PJ; Joshi RP; Pakhare A; Galhotra A; Kumar D; Behera BK; Topno RK; Gupta MK; Rustagi N; Trivedi AV; Thankappan KR; Gupta S; Garg S; Shelke SC;
    BMJ Open; 2021 Jun; 11(6):e044066. PubMed ID: 34187814
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Feasibility of monitoring Global Breast Cancer Initiative Framework key performance indicators in 21 Asian National Cancer Centers Alliance member countries.
    Ong SK; Haruyama R; Yip CH; Ngan TT; Li J; Lai D; Zhang Y; Yi S; Shankar A; Suzanna E; Jung SY; Ho PJ; Yusuf A; Nessa A; Jung KW; Fernando E; Baral S; Bagherian M; Pradhan P; Jugder U; Vongdala C; Yusof SN; Thiri K; Sripan P; Cairo C; Matsuda T; Sangrajran S; Kiak-Mien Tan V; Mehrotra R; Anderson BO
    EClinicalMedicine; 2024 Jan; 67():102365. PubMed ID: 38125964
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NCDs, time to deliver the role of the WHO Global Coordination Mechanisme on NCDs.
    Genay-Diliautas S; Malgouires C
    Med Sante Trop; 2018 Nov; 28(4):368-370. PubMed ID: 30799820
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevention and control of non-communicable diseases in antenatal, intrapartum, and postnatal care: a systematic scoping review of clinical practice guidelines since 2011.
    Jung J; Karwal EK; McDonald S; Turner T; Chou D; Vogel JP
    BMC Med; 2022 Sep; 20(1):305. PubMed ID: 36123668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.